Doctor profile · Federal record
Dr. Hing-Sheung Fung, MD
Rheumatology Physician · Waco, TX
- NPI 1073624292
- MIPS 76.0 / 100 · 2023
- 20 yrs on file
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
611 W Hwy 6 Ste 101
Waco, TX 767107545
(254) 755-4582
fax (254) 755-4585
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- February 16, 2022
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Texas #J1249
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073624292. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
216,008
Distinct HCPCS
10
Medicare allowed
$2,567,395
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 86,340 | 22 | $6 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 47,200 | 15 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 24,002 | 26 | $12 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 22,470 | 20 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 15,840 | 153 | $23 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,350 | 14 | $40 | |
J9312 |
Injection, rituximab, 10 mg | 4,450 | 12 | $56 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,070 | 12 | $33 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 709 | 181 | $70 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 674 | 489 | $123 |
In context: peer comparison
Among 1 peers in Waco Rheumatology Physician, average services per provider: 8,308. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$33,261
Transactions
224
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 38 | $16,522.04 | |
| Amgen INC. | 54 | $13,053.55 | |
| Janssen Biotech, INC. | 13 | $579.47 | |
| Ucb, INC. | 14 | $390.46 | |
| Abbvie INC. | 17 | $384.97 | |
| Novartis Pharmaceuticals Corporation | 10 | $315.71 | |
| Aurinia Pharma U.S., INC. | 6 | $303.57 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 14 | $273.01 | |
| Mallinckrodt Hospital Products INC. | 8 | $242.39 | |
| Ani Pharmaceuticals, INC. | 11 | $226.41 | |
| Lilly USA, LLC | 9 | $179.92 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $172.31 | |
| GlaxoSmithKline, LLC. | 14 | $152.75 | |
| Pfizer INC. | 9 | $137.25 | |
| Octapharma USA, INC. | 5 | $96.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
5,242
Patients
1,282
Total drug cost
$2,963,925
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 1,375 | 307 | $53,545 |
| Hydroxychloroquine Sulfate | Generic | 1,154 | 316 | $84,116 |
| Leflunomide | Generic | 401 | 126 | $20,398 |
| Tramadol Hcl | Generic | 345 | 62 | $4,111 |
| Prednisone | Generic | 318 | 82 | $3,972 |
| Folic Acid | Generic | 246 | 68 | $1,290 |
| Humira(Cf) Pen (Adalimumab) | Brand | 197 | 26 | $1,945,821 |
| Gabapentin | Generic | 179 | 37 | $3,445 |
| Colchicine | Generic | 175 | 49 | $18,383 |
| Allopurinol | Generic | 170 | 47 | $3,050 |
Frequently asked questions
What is Dr. Hing-Sheung Fung's medical specialty?
Dr. Hing-Sheung Fung practices Rheumatology Physician in Waco, TX.
Where does Dr. Hing-Sheung Fung practice?
Dr. Hing-Sheung Fung practices at 611 W Hwy 6 Ste 101, Waco, TX 767107545. Office phone: 2547554582.
What is Dr. Hing-Sheung Fung's NPI?
Dr. Hing-Sheung Fung's National Provider Identifier (NPI) is 1073624292, issued by NPPES.
What procedures does Dr. Hing-Sheung Fung commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.